Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TOP1 | P11387 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3391749 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL193773 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL309466 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL13134752 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL3392184 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL15459817 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL1017001 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL2065096 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL22128527 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL307897 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10433544-B2 | Herbicide | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2019-10-08 | — | — | US | claimed |
| US-20180279609-A1 | Herbicide | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2018-10-04 | — | — | US | claimed |
| WO-2018182774-A1 | HERBICIDE | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2018-10-04 | — | — | WO | claimed |
| US-9150666-B2 | Hydrolytically stable, hydrophilic adhesion-promoting monomers and polymers made therefrom | ADA FOUNDATION (US) | 2015-10-06 | — | — | US | claimed |
| US-20100105885-A1 | DEOXYKETOHEXOSE ISOMERASE AND METHOD FOR PRODUCING DEOXYHEXOSE AND DERIVATIVE THEREOF USING SAME | NAT'L UNIVERSITY CORPORATION KAGAWA UNIVERSITY (JP) | 2010-04-29 | — | — | US | claimed |
| EP-2161332-A1 | DEOXYKETOHEXOSE ISOMERASE AND METHOD FOR PRODUCING DEOXYKETOHEXOSE AND DERIVATIVE THEREOF USING THE SAME | National University Corporation Kagawa University (JP) | 2010-03-10 | — | — | EP | claimed |
| EP-4529452-B1 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | GIULIANI SPA (IT) | 2025-12-24 | — | — | EP | disclosed |
| US-20250170038-A1 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | GIULIANI S.P.A. (IT) | 2025-05-29 | — | — | US | disclosed |
| EP-4529452-A1 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | Giuliani S.p.A. (IT) | 2025-04-02 | — | — | EP | disclosed |
| WO-2023228079-A1 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | GIULIANI S.P.A. (IT) | 2023-11-30 | — | — | WO | disclosed |
| US-20230338257-A1 | ANHYDROUS CONCENTRATED HAIR CARE COMPOSITIONS IN THE FORM OF A PASTE | EVERIST INC. (CA) | 2023-10-26 | — | — | US | disclosed |
| US-20220120761-A1 | Urine metabolomics based method of detecting renal allograft injury | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-21 | — | — | US | disclosed |
| US-10433544-B2 | Herbicide | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2019-10-08 | — | — | US | disclosed |
| EP-2161332-B1 | DEOXYKETOHEXOSE ISOMERASE AND METHOD FOR PRODUCING DEOXYHEXOSE AND DERIVATIVE THEREOF USING SAME | UNIV KAGAWA NAT UNIV CORP (JP) | 2015-04-22 | — | — | EP | disclosed |
| US-8389248-B2 | Deoxyketohexose isomerase and method for producing deoxyhexose and derivative thereof using same | NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY (JP) | 2013-03-05 | — | — | US | disclosed |
| US-20120040383-A1 | Methods and Kits Relating To Metabolite Biomarkers For Colorectal Cancer | THE UNIVERSITY OF NORTH CAROLINA AT GREENSBORO | 2012-02-16 | — | — | US | disclosed |
| US-20100105885-A1 | DEOXYKETOHEXOSE ISOMERASE AND METHOD FOR PRODUCING DEOXYHEXOSE AND DERIVATIVE THEREOF USING SAME | NAT'L UNIVERSITY CORPORATION KAGAWA UNIVERSITY (JP) | 2010-04-29 | — | — | US | disclosed |
| EP-2161332-A1 | DEOXYKETOHEXOSE ISOMERASE AND METHOD FOR PRODUCING DEOXYKETOHEXOSE AND DERIVATIVE THEREOF USING THE SAME | National University Corporation Kagawa University (JP) | 2010-03-10 | — | — | EP | disclosed |
| WO-2009099824-A1 | HYDROLYTICALLY STABLE, HYDROPHILIC ADHESION-PROMOTING MONOMERS AND POLYMERS MADE THEREFROM | ADA FOUNDATION (US) | 2009-08-13 | — | — | WO | disclosed |
| US-20090188622-A1 | Hydrolytically Stable, Hydrophilic Adhesion-Promoting Monomers and Polymers Made Therefrom | ADA FOUNDATION (US) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105885-A1 | DEOXYKETOHEXOSE ISOMERASE AND METHOD FOR PRODUCING DEOXYHEXOSE AND DERIVATIVE THEREOF USING SAME | ALDOA, TALDO1, GPI | LMNA 4339/4885L3MBTL1 1091/4885TDP1 1706/4885 |
| US-20250170038-A1 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | MAS1, CYP51A1, EYA2 | LMNA 3628/4885L3MBTL1 4808/4885TDP1 3199/4885 |
| US-20230338257-A1 | ANHYDROUS CONCENTRATED HAIR CARE COMPOSITIONS IN THE FORM OF A PASTE | SUCLG1, CUTA, OTC | LMNA 3424/4885L3MBTL1 4873/4885TDP1 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.